tadalafil has been researched along with Age-Related Osteoporosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Ahmad, N; Blair, HC; Gera, S; Gumerova, A; Hadelia, E; Haider, S; Ievleva, K; Iqbal, J; Kim, SM; Korkmaz, F; Kuo, TC; Li, W; Liu, L; Liu, P; Lizneva, D; Mathew, M; Miyashita, H; New, MI; Perez-Pena, H; Ryu, V; Sant, D; Stanley, S; Sun, L; Tamler, R; Taneja, C; Tourkova, I; Yuen, T; Zaidi, M; Zhu, LL | 1 |
Alp, HH; Başbugan, Y; Ediz, L; Huyut, Z; Şekeroğlu, MR; Yildirim, S | 1 |
2 other study(ies) available for tadalafil and Age-Related Osteoporosis
Article | Year |
---|---|
Repurposing erectile dysfunction drugs tadalafil and vardenafil to increase bone mass.
Topics: Aging; Animals; Bone and Bones; Bone Density; Brain; Cell Differentiation; Cyclic Nucleotide Phosphodiesterases, Type 5; Drug Repositioning; Erectile Dysfunction; Humans; Male; Mice; Middle Aged; Models, Animal; Models, Molecular; Neurons; Osteoblasts; Osteoclasts; Osteogenesis; Osteoporosis; Osteoporotic Fractures; Phosphodiesterase 5 Inhibitors; Primary Cell Culture; Tadalafil; Vardenafil Dihydrochloride | 2020 |
The effect of PDE5 inhibitors on bone and oxidative damage in ovariectomy-induced osteoporosis.
Topics: Animals; Biomarkers; Bone and Bones; Bone Density; Chromatography, High Pressure Liquid; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Osteoporosis; Ovariectomy; Phosphodiesterase 5 Inhibitors; Pyrimidines; Rats, Wistar; Sulfonamides; Tadalafil; Treatment Outcome; Vardenafil Dihydrochloride | 2017 |